5S7-28029-72337
2 vaccinations
5 coded responses
22 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 245 / VA
- Registered
- 2021-03-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-02
Registered in v-safe
-
2021-03-02
Dose 1 — Pfizer-BioNTech
-
2021-03-02
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-03
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-16
-
2021-04-06
Dose 2 — Pfizer-BioNTech
-
2021-04-06
Survey response — day 0, dose 2MedDRA: Visual impairment — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessFree text: Visual disturbancesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend schoolAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-04-13
Health check-in — day 7, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-05-01
Survey response — day 21, dose 2MedDRA: Rash, Rash erythematous, Rash pruritic — Feeling: GoodFree text: New itchy red rashes on feet and inside of elbows.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-04
Survey response — day 28, dose 2MedDRA: Blister, Dizziness, Dizziness postural, Rash erythematous, Rash pruritic — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Blisters that that have turned into itchy red rashes on feet, ankles, insides of elbows, and underarms. Dizziness upon standing, from laying down to sitting, and at random times.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-18
Survey response — day 42, dose 2MedDRA: Dizziness, Rash, Rash erythematous, Rash pruritic, Rash vesicular — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Light headedness and red, itchy, blistery rash on top of feet, inside elbows, and along armsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-18
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-06
Survey response — 3 months, dose 2MedDRA: Rash, Rash erythematous, Rash pruritic, Rash vesicular — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Rash on inside of elbows, on ankles and backs of knees has spread to neck and shoulders. Blistery, itchy, red bumps. Rash initially developed within 48 hours of second Pfizer shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-06
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-19
- 2021-10-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Pfizer-BioNTech | |
| 2 | 2021-04-06 | Pfizer-BioNTech |
Call center
2 call center cases
2 unsuccessful
Free text
Release 7 — day 0, dose 2
Systemic reaction (other): Visual disturbances
Release 8 — day 21, dose 2
Symptoms: New itchy red rashes on feet and inside of elbows.
Release 8 — day 28, dose 2
Symptoms: Blisters that that have turned into itchy red rashes on feet, ankles, insides of elbows, and underarms. Dizziness upon standing, from laying down to sitting, and at random times.
Release 8 — day 42, dose 2
Symptoms: Light headedness and red, itchy, blistery rash on top of feet, inside elbows, and along arms
Release 9 — 3 months, dose 2
Symptoms: Rash on inside of elbows, on ankles and backs of knees has spread to neck and shoulders. Blistery, itchy, red bumps. Rash initially developed within 48 hours of second Pfizer shot.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blister | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Dizziness postural | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rash erythematous | ✓ | ✓ | ✓ |
| SD | Rash pruritic | ✓ | ✓ | ✓ |
| SD | Rash vesicular | ✓ | ✓ | ✓ |
| SRO | Visual impairment | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release